|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Available-for-sale debt securities, at fair value, net of allowance for credit loss of $881 and $631 (amortized cost: $1,553,900 and $1,466,145) | ||||||||||||||||||||
| Equity securities, at fair value (cost: $113,037 and $87,326) | ||||||||||||||||||||
| Other investments, at fair value (cost: $5,000 and $5,000) | ||||||||||||||||||||
| Investment real estate, net | ||||||||||||||||||||
| Total invested assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash and cash equivalents | ||||||||||||||||||||
| Prepaid reinsurance premiums | ||||||||||||||||||||
| Reinsurance recoverables | ||||||||||||||||||||
| Premiums receivable, net | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Income taxes recoverable | ||||||||||||||||||||
| Deferred income tax asset, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| LIABILITIES: | ||||||||||||||||||||
| Unpaid losses and loss adjustment expenses | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Advance premium | ||||||||||||||||||||
| Book overdraft | ||||||||||||||||||||
| Reinsurance payable, net | ||||||||||||||||||||
| Commission payable | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Other liabilities and accrued expenses | ||||||||||||||||||||
| Debt, net of issuance costs | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS’ EQUITY: | ||||||||||||||||||||
| Cumulative convertible preferred stock | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
| Treasury shares, at cost - 20,558 and 20,226, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income (loss), net of taxes | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
| Common stock, shares outstanding (in shares) | ||||||||||||||||||||
| Common stock, shares issued (in shares) | ||||||||||||||||||||
Loading...
